BJ9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Benitec Biopharma Inc

Watchlist Manager

Watchlist

Price: 0.0115 EUR Market Closed

Market Cap: €18.9k

B	Benitec Biopharma Inc XBER:BJ9	US
M	Microchip Technology Inc XHAM:MCP	US
C	Caseys General Stores Inc F:CS2	US
W	Western Union Co BMV:WU	US
	Christian Dior SE XETRA:DIO	FR
C	Caixabank SA SWB:48CA	ES
F	Fresenius Medical Care AG DUS:FME	DE
	Systemair AB STO:SYSR	SE
	COSCIENS Biopharma Inc OTC:CSCIF	CA
B	BRP Inc F:B15A	CA
B	Banco Santander SA XBER:BSD2	ES
	Magmatic Resources Ltd ASX:MAG	AU
	Archos SA F:AYH0	FR
	Perusahaan Gas Negara Tbk PT OTC:PPAAF	ID
M	Motorola Solutions Inc XBER:MTLA	US
T	Telefonaktiebolaget LM Ericsson XBER:ERCB	SE

Profitability Summary

Benitec Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

377%

Low Operating Margin

Negative 3Y Average Operating Margin

-76.007%

Low Net Margin

Negative 3Y Average Net Margin

-76.723%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-70.722%

Negative ROE

-55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1.738%

Declining ROIC

-1.633% > -7.449%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.